1066

Dr Anshul Gupta

Oncology Medical Oncology • 
9+ Years  experience
MBBS, MD(GENERAL MEDICINE), DM(ONCOLOGY)
09:00 - 11:00  •   Mon, Wed & Fri Hindi  •  English

DOCTOR UNAVAILABLE

No Slots Available. Please request a call back

Select Date

    > Loading available days...

Available Slots:

    Overview

    Dr. Anshul Gupta is a Consultant Medical Oncologist with 9 years of clinical experience and is currently associated with Apollo Hospitals, Noida. He holds an MBBS degree (2011), followed by an MD in General Medicine (2016) and a DM in Medical Oncology (2022), reflecting comprehensive training in internal medicine and advanced cancer care. His clinical expertise spans solid tumors and hematological malignancies, with special interests in breast cancer, urologic oncology, gynecologic cancers, soft tissue sarcomas, and rare malignancies such as extranodal NK/T-cell lymphoma. Dr. Gupta has a strong academic and research orientation, with notable work on AI-based decision making in urologic oncology, neoadjuvant chemotherapy strategies in HER2-positive breast cancer, systemic therapy in advanced dermatofibrosarcoma protuberans, and the use of combination therapies such as lenvatinib plus pembrolizumab in advanced endometrial cancer. His contributions have been recognized with accolades including First Prize in an Inter-College Medicine Quiz and the Youth Mentorship Award. Fluent in English and Hindi, Dr. Gupta is known for delivering evidence-based, patient-centric oncology care while actively engaging in academic mentorship and research-driven clinical practice.

    Apollo Hospitals Noida
    Apollo Hospitals, E-2, Sector-26, Noida, UP, 201301

    Awards

    • First Prize in Inter-College Medicine Quiz
    • Youth Mentorship Award

    Research and Publication

    • AI-Based Decision Making in Urology Oncology
    • Neoadjuvant Chemotherapy With or Without Anthracyclines in Combination With Single HER2-Targeted Therapy in HER2-Positive Breast Cancer
    • Extranodal NK/T-Cell Lymphoma
    • Systemic Therapy in Advanced Dermatofibrosarcoma Protuberans
    • Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer

    Could not find what you are looking for? 

    Request a Callback

    Image
    Image
    Request A Call Back
    Request Type